Cardiff University Biobank

Cystic fibrosis (disorder)

Cystic Fibrosis Collection

Year Started: 2020



Access:
Open to applicants
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 0 - 3 months
Freezer temperature logs 0 - 3 months
Treatment records 0 - 3 months


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 100%
Whole blood -60°C to -85°C Not applicable 100%
Sputum -60°C to -85°C Not applicable 51 - 75%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 75% -99%
Whole blood -60°C to -85°C Not applicable 75% -99%
Sputum -60°C to -85°C Not applicable 51 - 75%


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 75% -99%
Whole blood -60°C to -85°C Not applicable 75% -99%
Sputum -60°C to -85°C Not applicable 26 - 50%


Male

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 75% -99%
Whole blood -60°C to -85°C Not applicable 75% -99%
Sputum -60°C to -85°C Not applicable 26 - 50%

Acute myeloid leukemia, disease (disorder)

AML 15 Clinical Trial Collection

Year Started: 2002

Samples from the AML 15 Clinical Trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Followup records 3 - 6 months
Treatment records 3 - 6 months


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%
Primary cells Liquid nitrogen vapor phase Not applicable 11 - 25%


Male

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 51 - 75%
Primary cells Liquid nitrogen vapor phase Not applicable 51 - 75%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 75% -99%
Primary cells Liquid nitrogen vapor phase Not applicable 11 - 25%

Diabetic foot ulcer (disorder)

INDUCE: Point-of-care tests to assist antibiotic prescribing decisions for diabetic foot ulcer infections

Year Started: 2014



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
Commercial restriction, DNA restriction, Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Survey data 3 - 6 months
Treatment records 3 - 6 months


Unknown

Data not recorded

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C Not applicable 100%
Swab -60°C to -85°C Not applicable 75% -99%

Acute myeloid leukemia, disease (disorder)

AML 17 Clinical Trial Collection

Year Started: 2007

Samples from the AML 17 trial



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Followup records 3 - 6 months
Treatment records 3 - 6 months


Unknown

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Primary cells Liquid nitrogen vapor phase Not applicable 26 - 50%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen vapor phase Not applicable 51 - 75%